Martha Somerman - 12 Aug 2021 Form 4 Insider Report for BIOLASE, INC (BIOL)

Role
Director
Signature
/s/ Michael C. Carroll, attorney-in-fact for Martha Somerman
Issuer symbol
BIOL
Transactions as of
12 Aug 2021
Transactions value $
$0
Form type
4
Filing time
23 Aug 2021, 19:58:50 UTC
Next filing
10 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIOL Stock Appreciation Right Award $0 +98,955 $0 98,955 12 Aug 2021 Common Stock 98,955 $0.63 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Of the stock appreciation rights subject to this SAR, the stock appreciation rights vest on May 26, 2022.